Full Report

Know the Business

Suzlon is a vertically integrated Indian wind turbine OEM riding the second-largest cyclical recovery in its history. The story today is not technology — it's that a once-bankrupt company has rebuilt distribution, balance sheet, and product, and India's wind market is finally sized to absorb its 4.5 GW of low-cost manufacturing capacity. The market is pricing in flawless execution at 10x book; the asymmetric risks are receivables, project-execution slippage, and the next downcycle in tariff-driven bid demand — none of which the current narrative reflects.

1. How This Business Actually Works

Suzlon sells wind turbines, then earns an annuity for 20+ years servicing them. Everything else — EPC, forging, project development — exists to win the turbine sale and protect the lifetime cash stream attached to it.

The economic engine has three layers, and they have very different margin profiles. Knowing the mix is more useful than any P&L line item.

The WTG line is volume-and-mix driven. EBITDA margin moved from 13.7% to 16.0% inside two quarters of FY26 purely because of (a) which customer was supplied — average sales price is contract-specific — and (b) what share was supplied as EPC versus turbine-only. Project (EPC) revenue carries lower margin than turbine supply but locks in scope and crowds out competitors at the bid stage. Suzlon is deliberately raising EPC mix from 20% to a 50% target by 2028, which dilutes WTG margin but expands revenue per MW by ~2.5x.

OMS is the quietly important business. Suzlon manages 15.5+ GW of its own installed fleet under service contracts, with machine availability above 95%. Renom (76% acquisition completing in two tranches; ₹660 cr) extended the OMS franchise to 32 GW of non-Suzlon assets in India — turning a captive aftermarket into a multi-brand independent service provider. OMS contributes a quarter of revenue at materially higher margin and far lower working capital than WTG, and it grows mechanically as the installed base grows.

Operating leverage is the other lever. CEO Chalasani states breakeven was rebuilt from 1,300–1,400 MW to 650–700 MW. The 9M FY26 delivery run-rate of 1,625 MW is roughly 2.4x breakeven — every incremental MW now drops disproportionately to EBITDA. This is why FY25 ROCE jumped to 33% with revenue still below FY14 levels in absolute terms.

What truly drives incremental profit:

1. Order book conversion velocity — turbines sit in execution for 4–7 quarters; faster conversion = higher capital turnover.
2. Customer mix in any given quarter — large strategic accounts (e.g., Tata Power 838 MW) carry better realization than small captives.
3. Land and grid evacuation readiness — historically the binding constraint on commissioning.

2. The Playing Field

There is only one true Indian WTG-manufacturing peer (Inox Wind). The rest are downstream IPPs that buy turbines or industrial conglomerates with adjacent exposure. Treating them as comparables on multiples without that distinction is a classic analyst error.

Suzlon trades at 7.1x sales versus Inox Wind's 5.0x — the only fair comparison. The 40% premium is mostly the OMS annuity and the cleaner balance sheet. Adani Green and Tata Power operate on a different chassis: they are IPPs that finance and own generation assets, so their earnings scale with installed capacity and tariff, not turbine-build volume. Comparing P/E across these names is misleading; revenue multiples and ROCE are the only honest cross-cut.

What "good" looks like in WTG manufacturing globally is a 15–18% steady-state EBITDA margin, 25%+ ROCE through cycle, and book-to-bill above 1.0x. Suzlon's 9M FY26 numbers (18% EBITDA margin, 33% ROCE, 1.9x book-to-bill) are at peak-cycle highs — not a steady state.

3. Is This Business Cyclical?

Severely. Suzlon's revenue collapsed from ₹20,403 cr in FY14 to ₹2,973 cr in FY20 — an 85% peak-to-trough drawdown — and accumulated losses of ₹12,047 cr by FY20 wiped out the equity base. Anyone modeling this company off three years of recovery numbers is making a category error.

The cycle hits in five places, not one:

Demand. Tied to PPA awards. Central bidding (SECI) has paused on PPA-signing delays. State bidding (GUVNL, MPUVNL) is filling the gap, plus C&I/captive (51% of current order book) and PSU (13%). Concentration in central tariff bids is what killed FY18–FY20.

Working capital. This is the brutal one. Inventory days peaked at 503 in FY21; debtor days at 168 in FY20. Cash conversion cycle hit 315 days. Today: 145 days, but debtors are creeping up again (102 → 130 over two years). The FY26 receivable balance is ₹5,745 cr against revenue of roughly ₹14,000 cr full-year — DSO of 145+ days, with ₹2,100 cr of that subject to milestone completion before it becomes due.

Margins. Two-quarter swings of 200–300 bps purely on customer mix and EPC share. Not a stable margin profile.

Capital markets access. Suzlon survived only because of repeated equity issuances and debt restructurings (CDR, SDR, S4A, the 2023 QIP). The FY23 net profit of ₹2,887 cr was largely a non-cash debt-restructuring gain (other income ₹2,739 cr).

Project execution. Land, grid evacuation, customer financing — non-financial constraints that turn revenue into receivables and receivables into write-offs.

The balance sheet repair is the single most important fact in the equity story. Borrowings went from ₹17,059 cr (FY14) to ₹323 cr (FY25). Net cash now ₹1,556 cr. Reserves swung from -₹12,047 cr (FY20) to +₹3,374 cr (FY25). This is what gives the company a second life — not the order book.

4. The Metrics That Actually Matter

Forget P/E. The five numbers below carry the entire equity story; everything else is downstream of them.

Order book ÷ capacity is the single most useful number. At 6.4 GW order book against 4.5 GW capacity (1.4 years of work), the supply line is full — but not so full that bottlenecks slip schedules. Once book-to-bill stays under 1.0x for two consecutive quarters, the cycle has rolled over.

Quarterly deliveries matter more than revenue because they convert the order book to cash and run through the breakeven calculus. Sub-300 MW quarterly deliveries put the company back near breakeven; 600+ MW puts it at peak operating leverage.

WTG EBITDA margin volatility tells you who has pricing power. Suzlon's 200–300 bps quarterly swing on customer mix says it does not have stable pricing — it has stable cost structure with variable realizations.

OMS AUM is the part of the business that doesn't care about the cycle. The market underweights this because the WTG segment is louder.

Debtor + inventory days is the leading indicator of trouble. Watch this monthly during downturns; in FY18–FY19 it broke before the P&L did.

Net cash position is the survival metric. The single biggest reason this company has any equity value today is that the 2023 QIP reset the balance sheet from terminal to defensible.

5. What I'd Tell a Young Analyst

This is a high-quality business at a moment that is not high-quality to be entering it. The economics are good because the cycle is up and capacity utilization is rising; both will mean-revert.

Three things to watch each quarter:

1. Book-to-bill ratio — if it falls below 1.0x for two quarters, the order book is shrinking and operating leverage starts working in reverse.
2. Receivables aging — Suzlon's quarterly call now discloses the >1-year bucket. Anything above ₹500 cr there is a warning.
3. EPC share progression — the 50% target by 2028 means margins should compress predictably; if margins hold flat as EPC mix rises, something is being booked aggressively.

Two things the market is likely underestimating:

• The Renom acquisition gives Suzlon access to 32 GW of competitor-installed turbines for service. OMS scales without capex; this is the most valuable mix-shift the company has on the table.
• The forging/foundry business (SE Forge) at 33% YoY growth and ~20% EBITDA margin is being treated as a rounding error. It is exporting castings to defense and railways and benefits from a separate end-market cycle.

Two things the market is likely overestimating:

• Pricing power. A 13.7% WTG margin in a record-execution quarter, after multiple price hikes, is not the margin profile of a moat-protected business. Inox Wind's price competition is real and re-emerging.
• Earnings durability. FY25 net profit was inflated by a -43% effective tax rate (deferred tax asset recognition). Normalize this and FY25 PAT is ~₹1,400 cr, not ₹2,072 cr. The reported 23.9x P/E becomes ~35x.

What would change the thesis: a WTG EBITDA margin sustainably above 18% would suggest pricing power has emerged; OMS AUM growing 30%+ on Renom integration would prove the annuity scaling story; or a sub-300 MW delivery quarter would suggest the cycle has turned. None of those is in consensus.

The question is not whether Suzlon executes — it has been executing — but whether the multiple already prices that execution, and what the company looks like at trough operating leverage. The answer to the second question is the FY18–FY20 P&L, and that history sits one bid-cycle away.

The Numbers

Suzlon trades at roughly 24x trailing earnings, 5.2x trailing sales, and 9.9x book value after a balance-sheet reset that took borrowings from ₹17,059 cr to ₹397 cr in twelve years and a delivery run-rate that has tripled since FY24. The single metric most likely to rerate or derate the stock is WTG EBITDA margin durability — every 100 bps of sustained margin compression at current ₹15,000 cr revenue strips ₹150 cr of EBITDA, while trailing reported PAT of ₹3,229 cr is itself flattered by ₹1,260 cr of deferred-tax-asset recognition that is now unwinding. The market is pricing flawless conversion of a 6.4 GW order book at peak operating leverage; the numbers below test whether that pricing is defensible.

1. Snapshot — what the company is right now

Trailing twelve months ended Dec-2025 sum to ₹15,029 cr revenue and ₹3,229 cr PAT — the second highest annual run-rate in company history and the first time since FY14 the absolute revenue line is rising into a structurally positive equity base. Net cash of ₹1,359 cr (₹1,756 cr cash and investments minus ₹397 cr debt) at H1FY26 is the cleanest balance sheet in the listed history.

2. Twelve-year revenue and earnings power

Revenue is still 47% below the FY14 peak in nominal rupees. Operating profit broke into structural positive territory only in FY22 after seven consecutive years of negative or near-zero operating income. The FY23 ₹2,887 cr PAT was 95% non-operating — a debt-restructuring gain in "other income" — which is why the FY24 reset to ₹660 cr underlying earnings is the more honest reference point.

3. Margin profile — pricing power or operating leverage?

Operating margin has held a 14–17% band across FY22–FY25, narrower than the prior cycle but not yet stable enough to call structural. The FY23 net margin spike (48%) and FY25 net margin (19%) both rode non-operating items — debt-restructure gain in FY23 and a -43% effective tax rate in FY25 from deferred-tax-asset recognition. Strip those and FY25 underlying net margin is closer to 13%, in line with FY17 — not a step-change.

4. Quarterly direction — recent trajectory

Revenue compounded at roughly 30% per quarter sequentially over the last three quarters; operating profit lagged that pace, holding 17–19% of sales. Net profit is jagged because deferred-tax-asset recognition (Q4 FY25 and Q2 FY26) inflated two quarters and Q3 FY26 stripped most of it back out — the operating profit line is the cleaner read on the underlying business.

5. Are the earnings real? Cash conversion

Five-year CFO-to-net-income conversion: ₹3,095 cr cumulative CFO vs ₹5,542 cr cumulative net income — a 56% conversion ratio. Below the 80% floor that flags clean earnings. The gap is partly working-capital absorption (debtor days re-expanded from 72 to 130 over FY23–FY25) and partly the FY23 ₹2,739 cr non-cash other-income from debt restructuring. FY24 CFO of just ₹80 cr against ₹660 cr reported PAT was the cleanest tell — receivables consumed almost all the reported profit in cash terms.

6. Free cash flow and capex intensity

Capex is light — under 4% of revenue in most years — because Suzlon expanded by re-using existing manufacturing footprint as utilization climbed from sub-30% to 70%+. FY25 capex stepped up to ₹368 cr (3.4% of revenue) ahead of nacelle line additions. FCF turned positive again in FY25 at ₹724 cr, but on a ₹2,072 cr PAT base the FCF/PAT ratio is 35% — still poor cash quality.

7. The balance-sheet rebuild — the single fact this stock rests on

Reserves crossed zero only in FY24 — meaning prior to that, accumulated losses exceeded share capital and the company technically had no equity buffer. The 2023 QIP and 2022 rights issue raised ₹3,300+ cr that, combined with the ₹2,887 cr FY23 restructuring gain, eliminated negative reserves. Borrowings of ₹397 cr at H1FY26-end against ₹1,776 cr fixed assets and a ₹1,756 cr cash position is the strongest balance sheet in the company's listed history.

8. Returns on capital — peak-cycle highs

ROCE has stair-stepped from 10% in FY21 to 33% in FY25. The FY17 spike of 53% — at a point where the company was accounting-profit-positive on debt restructurings — is a useful warning that ROCE on a thin equity base flatters the read. With reserves now positive ₹3,374 cr and rebuilt invested capital, the FY25 number is the first ROCE since FY14 that survives a normalized capital-base calculation.

9. Working capital — where cycles hide

Debtor days expanded from 72 (FY23) to 130 (FY25) while revenue accelerated — the classic late-cycle pattern where receivables grow faster than collections. Inventory days have moderated from the FY21 peak of 503, but the FY25 reading of 171 is still 67 days above FY23. Net working-capital absorption in FY26 is the single highest-conviction red flag in the numbers.

10. The critical valuation chart — Price/Sales vs its own history

The 12-year median P/S is 0.69x. Current TTM P/S of 5.16x is 7.5x the historical median and 39% off the FY24 peak of 8.4x. Even applying the FY24 peak multiple as a permanent re-rating premium (accepting the new business model deserves a structural step-up), today's multiple still requires revenue to compound above 30% for two more years to grow into the price. Bull-case execution is already in the multiple.

11. P/E and P/B history — only meaningful when earnings exist

Years with negative or near-zero EPS produce meaningless P/E — only seven of twelve fiscal years are ratio-able. The cleanest comparison is FY17 (12.7x P/E) versus today (23.9x P/E TTM): nearly double the multiple on a profit base that depends on ~₹650 cr of one-time deferred-tax-asset recognition. P/B at 9.9x current is the most extreme end of the equity multiple — only the FY24 reading of 14.0x was higher, and that was at a smaller book base.

P/E of 23.9x looks cheap against the 48x sector. But "sector" here aggregates conglomerates (Siemens, BHEL at 80x and above) trading on infrastructure-thematic premia, not WTG OEMs. Against the only direct peer, Inox Wind at 35x P/E and 5.0x P/S, Suzlon trades at a 32% P/E discount and a 3% P/S premium — the gap opens because Inox's earnings base is smaller and noisier, not because Suzlon has structural cheapness.

12. Quality scorecard — what the data says

The growth and balance-sheet halves of the scorecard are excellent. The cash-quality and earnings-quality halves are not. A reader who accepts the 41% ROE and ignores the 35% FCF/PAT is reading half the company.

13. Peers — apples-to-apples on multiples

Suzlon and Inox are the only true WTG-OEM comparables. They cluster within 3% of each other on revenue multiple and within 400 bps on operating margin — confirming there is no premium-pricing power between the two pure-play OEMs. Adani Green's 15.9x P/S and 67% operating margin reflect an IPP business model (asset-financed generation, not turbine sales) that should not be in a multiple-reversion calculation.

14. Fair value — three scenarios in native rupees

What the numbers confirm and contradict

Confirm: the balance-sheet repair is real (borrowings down 98%, reserves positive for the first time in a decade), operating leverage is real (16–17% OPM with revenue still 47% below peak), and the order book is real (6.4 GW vs 4.5 GW capacity). Contradict: the stock is not "almost debt free and cheap." On TTM P/S the multiple is 7.5x its 12-year median, on cash terms FCF converts only 35% of reported PAT, and FY25 net profit is materially flattered by deferred-tax-asset recognition that is now unwinding through FY26. Watch next quarter: debtor days (the ₹5,745 cr receivable at FY25 against ₹15,029 cr TTM revenue is already at 145+ days), the WTG EBITDA margin (a sustained reading above 18% would indicate pricing power has finally emerged), and the rate at which the order book converts at — book-to-bill below 1.0x for two quarters is the cycle signal.

Where We Disagree With the Market

The market is pricing Suzlon on the wrong denominator. Consensus treats headline P/E of 24x versus the 48x sector median and calls the stock "cheap" — but ₹77,000 crore of market cap sitting on ₹1,092 crore of operating cash flow is a 70x EV/CFO multiple, and on free cash flow the stock trades above 100x. The analytical error is straightforward: ten of eleven analysts anchor to reported earnings that include ₹1,355 crore of cumulative deferred-tax-asset recognition while the underlying cash conversion ratio over three years is 0.30x. The market believes the cash-conversion deficit is a temporary scaling artifact tied to the delivery-to-commissioning gap; our evidence suggests the receivables trajectory is structurally linked to India's grid evacuation and land-readiness constraints, which are not inside Suzlon's control and will not resolve in one or two monsoon cycles. The debate gets settled by Q4 FY26 and Q1 FY27 results: if CFO exceeds reported net income for two consecutive quarters with debtor days declining below 110, the market is right and the stock is genuinely cheap on cash; if not, the 24x headline P/E is fiction and the real multiple is 50-70x operating cash flow.

Variant Perception Scorecard

Variant strength is 62 — meaningful but not extreme. The consensus is clearly observable (10/11 Buy ratings, ₹63-78 targets, universally anchored to headline P/E), and the forensic evidence on cash conversion is strong. What holds the score below 70 is the DTA runway complication: management disclosed ₹1,100 crore of remaining DTA as of Q3 FY26, sufficient to shield roughly ₹4,400 crore of future profits. This means the "DTA exhaustion cliff" that forms the bear case's most dramatic price catalyst is pushed out 2-3 years at current profitability — the bear's timing is wrong even if the bear's arithmetic is right. The variant is less about direction and more about which metric the market should be using to value this company. Resolution comes within 6 months through Q4 FY26 (late May 2026) and Q1 FY27 (August 2026) results, which will expose whether the cash-conversion deficit is closing or widening.

Consensus Map

The Disagreement Ledger

Disagreement 1: Wrong denominator. Consensus would say: "P/E of 24x is cheap versus the sector at 48x, and operating profit is real, so the market is paying a reasonable price for a company delivering 60% revenue growth." Our evidence disagrees because the gap between reported profit and operating cash is not noise — it is structural. Over three years, only 30 paisa of every reported rupee of profit arrived as cash. FY24 was the starkest example: ₹660 crore of PAT produced ₹80 crore of CFO, with payables doubling to mask even worse underlying cash generation. If we are right, the market would have to concede that the relevant multiple is not P/E (which can be flattered by DTA and accrual timing) but EV/CFO or P/FCF — on which Suzlon trades at 70x and 107x respectively, multiples that no cyclical single-product industrial deserves. The cleanest disconfirming signal: two consecutive quarters where CFO exceeds net income, proving that the cash-conversion gap was genuinely a timing issue rather than structural revenue-recognition aggression.

Disagreement 2: Structural receivables. Consensus would say: "The 776 MW erected-not-commissioned backlog is a timing mismatch that resolves as monsoon delays clear; management confirmed receivables are 'not overdue,' with ₹2,100 crore not yet due." Our evidence complicates this because debtor days have expanded from 72 to 130 over three years — not one monsoon season — and the constraint is not Suzlon's execution pace but India's grid evacuation and land readiness infrastructure, which moves on government and utility timelines, not OEM timelines. The FY26 record of 6.05 GW national wind installations shows the demand is real, but commissioning bottlenecks are industry-wide. If receivables keep outgrowing revenue in FY27, the ₹5,745 crore receivable book becomes a write-off risk the moment the bid cycle slows — identical to the FY18-FY20 pattern. The disconfirming signal: DSO declining below 110 for two quarters while the order book stays above 5 GW.

Disagreement 3: OMS mispricing. Consensus would say: "OMS is a nice kicker but the WTG order book drives the stock." This is analytically lazy. OMS contributes 23% of revenue at nearly double the WTG margin, with minimal working capital and mechanical growth tied to India's expanding installed base (now 56+ GW). The Renom acquisition, completed for under 1% of market cap, triples the addressable fleet from 15.5 GW to 47.5 GW. No analyst runs a sum-of-parts. If they did, OMS at 8-10x revenue (consistent with global wind service multiples) would account for ₹20,000-25,000 crore of the ₹77,000 crore market cap — implying the market assigns 7-8x P/S to the cyclical WTG business, far above the 2-4x that comparable hardware OEMs command globally. The disconfirming signal: OMS revenue stalling or Renom integration consuming cash rather than generating annuity margin.

Disagreement 4: DTA timing. Consensus bears anchor to DTA exhaustion as the next-quarter trigger for a 40% PAT cliff. The evidence says otherwise: ₹1,100 crore of DTA remains available at Q3 FY26, sufficient to shield ₹4,400 crore of future profits. At normalized PBT of ₹1,500-2,000 crore annually, this provides 2-3 years of near-zero effective tax — not the imminent cliff the bear case requires. This does not make the stock "cheap" (the cash-flow problem persists regardless of tax treatment), but it removes the most binary near-term bear catalyst. The disconfirming signal: accelerated DTA recognition that exhausts the pool faster than the 2-3 year runway, or a regulatory change in carried-forward loss utilization rules.

Evidence That Changes the Odds

How This Gets Resolved

What Would Make Us Wrong

The most dangerous assumption in the variant view is that the cash-conversion deficit is structural rather than a temporary artifact of Suzlon's scaling phase. There is a plausible alternative: at 2.4x breakeven utilization with quarterly deliveries tripling in two years (from 200 MW to 617 MW), working capital mechanically expands before collections catch up. The 776 MW erected-not-commissioned at December 2025 is physically verifiable — those turbines are standing in fields waiting for grid connectivity, not fictitious revenue. Management's disclosure that ₹2,100 crore of receivables are "not yet due" (tied to milestone completion) means the bulk of the receivable growth may be contractually appropriate, not aggressive recognition. If commissioning velocity accelerates in H1 FY27 as monsoon clears and grid evacuation improves, the delivery-to-cash lag closes within two quarters. In that scenario, the 0.30x three-year CFO/NI would be an artifact of the fastest scaling period in Suzlon's history — not a structural defect — and CFO/NI normalizing above 0.70x would validate the 24x P/E as the correct metric, proving the stock genuinely cheap against the sector.

The OMS undervaluation thesis is similarly fragile. A sum-of-parts that assigns 8-10x revenue to the OMS segment assumes Renom integration goes cleanly and the multi-brand model scales without margin dilution. Renom was a private company with limited disclosure; the acquired working capital profile, customer churn, and contract quality are unknowns. If OMS margin compresses from 25% toward 18% as Renom scales, the SOTP premium disappears, and OMS reverts to a modest supporting narrative rather than a distinct value driver.

Finally, the DTA timing disagreement cuts both ways. If the ₹1,100 crore remaining DTA provides a 2-3 year runway, it also means headline earnings will remain inflated for 2-3 years — giving the stock time to grow operating earnings into its multiple. A company that grows operating profit at 30% annually for three years under near-zero effective tax can legitimately compound EPS even as the DTA unwinds. By FY28, if PBT reaches ₹3,000+ crore (consistent with management's scaling ambitions), a 25% normalized tax rate produces ₹2,250 crore of sustainable PAT — which at today's market cap yields a 34x forward P/E. That is expensive for a cyclical but defensible for a company with a 6+ GW order book, 33% ROCE, and a growing annuity stream. The bull scenario is not impossible; it just requires flawless execution for three more years by a company that lost money in eight of its last twelve fiscal years.

The first thing to watch is: the standalone trade receivable balance and DSO in Q4 FY26 results (late May 2026) — if receivables grow faster than revenue for a fourth consecutive year, the structural cash-quality thesis is confirmed regardless of what the P&L shows.

Bull and Bear

Verdict: Watchlist — the business transformation is real, but the stock already prices flawless execution at peak operating leverage while cash conversion remains structurally unproven. The single most important tension is whether the 0.30x three-year cash-conversion ratio is a temporary scaling artifact or the early signal of a receivables write-off cycle. Bull wins on business quality and structural positioning; Bear wins on valuation and earnings integrity. The evidence that would tip the verdict to Lean Long is two consecutive quarters of CFO exceeding net income with debtor days declining below 110 — proving the P&L is producing real cash, not just accounting profit. Until that proof arrives, the risk-reward at 49–72x adjusted earnings does not compensate for the downside history of a company that lost money in 8 of 12 fiscal years.

Bull Case

Bull's target: ₹75 (32% upside from ₹56.8). Method: FY27E normalized EPS of ₹2.50 at 30x P/E — a discount to the 48x sector median, justified by superior ROCE and OMS annuity but haircut for cash-conversion risk. Timeline: 12–18 months through Q2 FY27 results (November 2026). Primary catalyst: Q4 FY26 results (May–June 2026) confirming 60% revenue growth guidance and WTG EBITDA margin stability above 16%. Disconfirming signal: book-to-bill falling below 1.0x for two consecutive quarters.

Bear Case

Bear's downside target: ₹35 (38% downside from ₹56.8). Method: P/S compression to 3.0x on trailing revenue (still 4.3x the 12-year median), cross-checked against 25x normalized P/E on ₹1,100 Cr adjusted PAT. Timeline: 12–18 months spanning two earnings cycles where DTA tailwind exhausts and receivables mature. Primary trigger: Q4 FY26 or Q1 FY27 earnings miss where headline PAT drops 40%+ as DTA recognition ends. Cover signal: two consecutive quarters of CFO exceeding net income with debtor days declining below 110.

The Real Debate

Verdict

Verdict: Watchlist. Bear carries more weight on the question that matters most — whether reported earnings are real. The adjusted P/E of 49–72x on a cyclical single-product WTG manufacturer with 0.30x three-year cash conversion is a valuation that demands proof the P&L produces cash, and that proof has not arrived. The earnings quality tension is decisive: if DTA exhaustion drops headline PAT by 40% in the next two quarters, the sell-side estimate reset will compress multiples regardless of order-book strength. Bull's structural arguments — OMS annuity, operating leverage, and the cleanest balance sheet in Suzlon's history — are genuine and differentiated, but they are already embedded in a 5.16x P/S that is 7.5x the 12-year median. The condition that changes this verdict is straightforward: two consecutive quarters where CFO exceeds net income and debtor days decline below 110, proving the cash-conversion deficit is a commissioning-timing artifact rather than structural revenue-recognition aggression. Until that evidence materializes, the business deserves a watchlist and the stock does not deserve capital.

Catalysts

The next six months hinge on Q4 FY26 results (expected late May 2026) — the single quarter that validates or breaks management's 60% revenue growth guidance and, more importantly, reveals whether the ₹1,355 Cr cumulative DTA tailwind has exhausted, forcing consensus to reprice from ₹2,000+ Cr headline PAT to ₹1,100–1,400 Cr normalized earnings. The calendar beyond Q4 is moderately loaded: Q1 FY27 results (August 2026), the first Blue Sky European order announcement (H2 CY2026), and AGM (August–September 2026). But only the earnings normalization and receivables trajectory can change underwriting. Everything else is narrative.

Ranked Catalyst Timeline

Impact Matrix

Next 90 Days

Binder Error: Set operations can only apply to expressions with the same number of result columns

The 90-day calendar is dominated by one event: Q4 FY26 results. If the company delivers on 60% growth and WTG margin holds, the stock's April 2026 rally gets validated by fundamentals. If it misses — particularly on receivables or cash conversion — the rally is a short-covering squeeze into an earnings downgrade cycle. There are no other material hard-dated catalysts inside 90 days. The calendar beyond Q4 is moderately loaded (Q1 FY27, AGM, Blue Sky orders) but none of those events are as binary.

What Would Change the View

Three observable signals would most shift the investment debate over the next six months. First, two consecutive quarters of CFO exceeding reported net income with DSO declining below 110 — this is the bear's cover signal and would prove that the 0.30x three-year cash conversion was a temporary scaling artifact rather than a structural quality defect; if it happens alongside the DTA exhaustion, the market would reprice the company on operating cash flow rather than headline earnings, which is a far more durable multiple. Second, book-to-bill falling below 1.0x for two consecutive quarters — this is the bull's disconfirming signal and would indicate the domestic wind cycle is rolling over before Suzlon has fully converted its 6.4 GW backlog; the last time this happened (FY17–FY18), revenue subsequently fell 85% peak-to-trough. Third, a signed Blue Sky order from a European customer — this would transform the variant perception that Suzlon is a domestic-only cyclical into a global-platform story, and would be the first time in a decade that Suzlon had a credible international revenue pipeline funded from strength rather than leverage. The Blue Sky signal is lower probability but higher narrative impact; the cash conversion and book-to-bill signals are the ones that change sizing.

Suzlon's story is one of India's most dramatic corporate arcs: a textile entrepreneur's wind energy bet that became a global top-5 player, then nearly died under ₹16,000+ crore of acquisition-fueled debt, and is now resurrecting as India's dominant domestic wind manufacturer. The narrative has shifted three times — from global conqueror (2006-2009) to debt survivor (2010-2020) to domestic champion (2021-present). Management credibility, destroyed by a decade of broken promises and a SEBI penalty for undisclosed order cancellations, has been substantially rebuilt under JP Chalasani's post-restructuring leadership — but the ambitious 60% growth guidance for FY26 is the first real test of whether the new team can set aggressive targets without over-reaching.

1. The Narrative Arc

Three distinct eras define Suzlon. The first was Tulsi Tanti's global ambition: a textile businessman who bought wind turbines to power his factory in 1994, then built India's largest wind company, took it public in 2005, and spent over ₹7,000 crore acquiring Hansen Transmissions (Belgium, gearboxes) and REpower Systems (Germany, offshore). By 2009, Suzlon was a top-5 global wind turbine maker. Tanti was among the world's richest energy entrepreneurs.

The acquisitions killed the balance sheet. The 2008 financial crisis froze credit, orders evaporated, and Suzlon could not service the debt. What followed was a decade of restructuring — CDR in 2013, Senvion divestiture, a Dilip Shanghvi equity bailout in 2015, and finally a formal debt restructuring in July 2020 that cut interest costs by more than 70%. Through this entire period, Suzlon bled cash: cumulative net losses from FY2014 to FY2022 exceeded ₹19,000 crore.

The turnaround began in FY2023 with the QIP that made the company net debt-free, and accelerated with the S144 turbine platform. FY2025 was the validation year: ₹10,890 crore revenue, ₹2,072 crore PAT, 1,550 MW delivered. Now, with Ajay Kapur as Group CEO and the Blue Sky 5 MW platform unveiled for European markets, Suzlon is attempting "Global Pivot 2.0" — except this time from a position of domestic strength rather than debt-fueled aspiration.

2. What Management Emphasized — and Then Stopped Emphasizing

Four narrative shifts stand out across eight quarters of transcripts:

Turnaround story fades, execution story takes over. In Q4 FY24, the dominant theme was governance — an emergency Sunday call to address an independent director's resignation. By Q1 FY25, the narrative had shifted entirely to "unparalleled performance" and record order books. By Q1 FY26, nobody mentioned debt at all. The turnaround arc was complete; what replaced it was an execution story.

Order book dominance peaked, then became table stakes. From Q1 FY25 through Q1 FY26, every call led with order book records (3.8 GW to 5.7 GW). By Q2-Q3 FY26, the order book was still growing (6.4 GW) but management spent more time on how they would execute than what they had won. The constraint shifted visibly from "can we win orders" to "can we commission what we've won."

Land/EPC strategy emerged as the new narrative center. Barely mentioned in early FY25, by Q2 FY26 land development had become the dominant strategic theme: 23+ GW pipeline identified, 7+ GW acquisition underway, 1,150 MW land acquired. The EPC mix target of 50:50 by FY28 (from 20% in H1 FY26) became management's primary strategic lever for solving the execution gap.

Governance dropped off completely. After consuming the entire Q4 FY24 call (Marc Lancet resignation), governance was mentioned once more in Q2 FY25 and then vanished. No structural changes were announced; the Khaitan audit found "no non-compliances." Whether governance actually improved or just stopped being discussed is an open question.

3. Risk Evolution

The risk profile has inverted. Debt and liquidity — the existential risks that defined Suzlon for a decade — have been eliminated. In their place, three operational risks now dominate:

Execution delays are the new existential constraint. In 9 months of FY26, Suzlon delivered 1,625 MW but commissioned only 442 MW. The 2,354 MW execution pipeline includes 568 MW erection-complete but waiting for grid connection, land clearance, or customer-side balance-of-plant. Management's own admission: "We could have easily done 750 MW in Q3 without any problem. But then your projects have got to be ready to offtake."

Land acquisition has become a first-order problem. As JP Chalasani noted in Q3 FY26: "acquiring land, negotiating with farmers, is becoming a major issue." Right-of-way issues "crop up every single day." This is why Suzlon's EPC strategy exists — by developing land themselves, they control the bottleneck. But EPC is only 27% of the order book today.

Grid and transmission gaps are systemic. In Q3 FY26, 253 MW of turbines were pre-commissioned but waiting for grid connectivity. An additional 80 MW were stuck due to MNRE-MoP confusion over temperature classification. These are policy-level risks that Suzlon cannot solve alone.

4. How They Handled Bad News

Suzlon's post-restructuring management has been more transparent about misses than its pre-2020 leadership — but still exhibits a pattern of reframing setbacks as sector-wide issues and upgrading the narrative before acknowledging the gap.

The governance resignation (Q4 FY24). When independent director Marc Lancet resigned citing transparency concerns, management convened a Sunday call — itself a strong signal. JP Chalasani's response was notable for its structure: acknowledge the feedback, deny any financial or legal wrongdoing four times, and reframe governance gaps as "process improvements" during a scaling phase. The key phrase — "I repeat, there are no lapses" — was defensive but direct. The unresolved question: Marc Lancet specifically praised the operational turnaround but flagged information flow to the board. No structural fix was announced, and the topic disappeared from subsequent calls.

The FY25 industry execution miss. Management initially guided 5-5.5 GW of industry-wide installation for FY25 (Q1 FY25). By Q3, this was quietly revised to 3.5-4 GW. The actual came in around 4.2 GW. Management handled this by attributing the miss to transmission delays and monsoon severity — both true — while emphasizing Suzlon's own record delivery pace. The reframe worked because Suzlon's market share grew even as the market shrank.

The Q3 FY26 delivery miss vs. expectations. Q3 FY26 delivered 617 MW — a company record — but below the linear run-rate needed for 60% growth. Management's response: "Highest delivery we ever did in a single quarter… expectation was different… arithmetic calculation." This is technically honest but reveals a pattern: set a bold annual target, celebrate quarterly records, and when the math gets tight, lean on "we don't guide quarterly."

WTG margin volatility. Margins swung from 26.9% (Q2 FY26) to 13.7% (Q3 FY26). Management attributed this to "customer mix" and "ASP impact" — plausible for a project-based business, but the range is wide enough to undermine the 23% guidance as a reliable anchor.

5. Guidance Track Record

The pattern: Management under-promised on margins (guided mid-teens, delivered 23.6%) and over-promised on industry volumes (guided 5.5 GW, actual 4.2 GW). The distinction matters: margin outperformance was within Suzlon's control, while volume miss was sector-wide. On the one metric that combines ambition with accountability — the 60% FY26 growth target — the jury is still out, and the math is tight.

Score rationale: The pre-2020 track record is genuinely poor — undisclosed order cancellations (SEBI penalty), a bond default, and billions written off on acquisitions. Post-restructuring, management has consistently delivered on balance sheet commitments, margin promises, and capacity ramp. The 60% FY26 guidance is the first time this team has set a specific, ambitious growth target. If they deliver, credibility rises to 7-8. If they miss, it confirms that Suzlon management — new or old — tends to promise more than the system can deliver.

6. What the Story Is Now

The current story is: India's wind sector is structurally growing, Suzlon is the dominant domestic player, and the balance sheet is clean for the first time in 15 years.

What has been de-risked:

The balance sheet is resolved. Net cash of ₹1,556 crore, net worth of ₹8,332 crore, almost debt-free — a company that defaulted on bonds in 2019 is now cash-surplus. The S144 turbine platform is validated with 5+ GW in cumulative orders and 92% of the order book. The OMS business (15.5 GW, 95%+ availability) provides recurring revenue and margin ballast.

What still looks stretched:

The 60% growth guidance requires a record Q4 FY26 — roughly ₹6,200 crore in revenue and 855 MW in deliveries — when the best-ever quarter was 617 MW (Q3 FY26). The delivery-to-commissioning gap persists: 1,625 MW delivered in 9M FY26 versus only 442 MW commissioned. This gap will eventually create customer pushback or receivable stress. Receivables already stand at ₹5,745 crore, with PSU contracts pushing longer payment cycles.

What to believe versus discount:

Believe the order book (6.4 GW, 10 consecutive quarters of growth) and the margin structure (23%+ WTG contribution margins on a through-cycle basis). Believe the domestic market story: India needs 8-10 GW of annual wind additions by FY28, and Suzlon has 31% of the installed base.

Discount the international expansion for now. Suzlon's last attempt at going global ended in near-bankruptcy. The Blue Sky turbine and Paulo Soares hire are early signals, not revenue. Discount the smooth 60% growth glide path — the execution ceiling is set by Indian infrastructure, not Suzlon's manufacturing capacity. And discount the margin stability: Q3 FY26's 13.7% WTG margin swing shows that project mix can compress margins sharply in any given quarter.

Financial Shenanigans

Suzlon's forensic risk score is 52 / 100 (Elevated). The headline earnings story — record profits, debt-free balance sheet, 41% ROE — crumbles under cash-flow scrutiny. Two of the three highest-profit years in the last decade (FY23 and FY25) were dominated by non-cash items: a ₹2,739 cr debt-restructuring gain and a ₹1,355 cr cumulative deferred-tax-asset recognition. Three-year cash conversion of earnings is 0.30x — meaning 70 paisa of every reported rupee of profit never showed up as operating cash. Meanwhile, trade receivables on the standalone balance sheet surged 230% in FY25 against 67% revenue growth, pushing debtor days from 72 to 130 in two years. The one thing that would upgrade this score: two consecutive quarters of CFO exceeding reported net income with stable debtor days.

Breeding Ground

The governance structure carries moderate risk for an Indian industrial with this history. The Tanti family controls the company operationally but owns only 11.7% of equity — the lowest promoter holding in the stock's history, and well below the 25%+ threshold that aligns founder incentives with minority shareholders. The reduction is not voluntary discipline; it is the mechanical result of a decade of dilutive equity raises (FY21 QIP, FY22 OCD-to-equity conversions, FY23 rights issue) needed to survive ₹17,000+ cr of debt. In October 2025, the Tanti family sold 20 cr shares (~2.9% stake) via a block deal worth ₹1,309 cr — with a 180-day lock-in on further sales.

The breeding-ground risk is moderate. The company has genuinely been through near-death — CDR, SDR, S4A, ICA, Resolution Plan — which both explains the diluted promoter stake and creates a cultural tolerance for aggressive reporting (you don't survive six restructurings without learning to present numbers favorably). The FY25 restatement of FY24 standalone comparatives, noted by the auditor, is an open question: the scope and materiality of this restatement are not detailed in available data, which is itself a disclosure concern.

Earnings Quality

Suzlon's operating earnings are genuinely improving — but headline net profit in three of the last four reporting periods was materially inflated by non-cash items that do not represent ongoing earning power.

The non-cash distortion map:

FY23 net profit of ₹2,887 cr included ₹2,739 cr of "other income" — overwhelmingly the non-cash gain from converting ₹4,100 cr of OCDs to equity and writing off CCPS obligations under the 2020 resolution plan. Stripping this, FY23 operating net profit was roughly ₹148 cr. FY25 net profit of ₹2,072 cr included ₹638 cr from recognizing a deferred tax asset on carried-forward losses (PBT was only ₹1,447 cr). Adjusting for this, FY25 earnings were roughly ₹1,434 cr — still a strong improvement, but 31% below the headline.

In Q2 FY26, the same pattern repeated: PBT of ₹562 cr became net profit of ₹1,279 cr after a ₹717 cr DTA recognition. Cumulative DTA recognized across these two periods: ₹1,355 cr. This is legitimate accounting — the company has massive carried-forward tax losses from its FY14–FY20 losses — but the recognition is a management judgment call on future profitability, and each recognition is one-time.

Receivables vs revenue — the critical divergence:

Standalone trade receivables surged from ₹546 cr (FY23) to ₹3,683 cr (FY25) — a 574% increase over two years while revenue grew 82%. The standalone numbers are more useful than consolidated here because Suzlon's Indian WTG business is the core. Debtor days on a consolidated basis rose from 72 to 130 in the same window. For a WTG manufacturer where revenue recognition is milestone-based, this divergence signals one of three things: (a) customers are paying slower, (b) project milestones are being recognized before cash collection is certain, or (c) the mix has shifted toward longer-payment-cycle customers. All three reduce earnings quality even if revenue recognition is technically correct.

Margin trend — the clean signal:

Operating margins at 14–19% across 11 quarters are the cleanest signal in the P&L. These are not cosmetically inflated by one-time items — operating profit excludes the other income and tax items that distort the bottom line. The consistency supports the thesis that the core WTG business is genuinely profitable. The 200–300 bps quarterly swing is customer-mix driven, not an accounting artifact.

Cash Flow Quality

This is where the forensic case is strongest. Suzlon's operating cash flow has persistently and severely lagged reported net income, and the gap is not closing at the pace the revenue ramp suggests.

The 3-year CFO/NI of 0.30 is the single most damning number in this report. For every ₹1 of reported profit, Suzlon generated only ₹0.30 of operating cash. FY24 is the worst: ₹80 cr of CFO on ₹660 cr of net income. Even FY25, the "best operating year in a decade," converted only 53% of earnings to cash.

The mechanism: The gap comes from two sources. First, non-cash items inflating the denominator (debt restructuring gain in FY23, DTA in FY25). Second, working capital absorbing cash as the business scales.

Working capital — the cash sponge:

The cash conversion cycle at 145 days looks stable. But beneath this aggregate, the components are shifting in an unfavorable direction: DSO rising (72→130), DPO compressing from its FY24 high (165→156). The FY22–FY23 period was the cash-collection sweet spot; FY25 is a working-capital-intensive scaling phase. Standalone inventory more than doubled (₹1,188 cr → ₹2,857 cr), consistent with building for a 6.4 GW order book — but this is cash out the door that hasn't yet returned.

The accrual ratio of 0.097 (FY25) confirms the pattern: net income significantly exceeds cash generation, and the gap is accumulating on the balance sheet as receivables and inventory.

Metric Hygiene

Suzlon reports under Indian GAAP (Ind AS) and does not heavily rely on non-GAAP or adjusted metrics. The primary investor-facing KPIs — order book (GW), quarterly deliveries (MW), and operating margin — are physically verifiable and consistently defined.

The most forensically relevant finding in metric hygiene is what Suzlon does not emphasize. The company highlights order book size, delivery records, and operating margins — all of which are genuinely strong. It does not prominently flag the 230% standalone receivable surge, the 12% FY24 cash conversion, or the fact that ₹1,355 cr of cumulative DTA recognition over two periods accounts for roughly a quarter of reported two-year profits. The headline P/E of 23.9x — cited widely and used by sell-side analysts — includes these DTA gains. On a normalized-tax basis (25% effective rate on PBT), FY25 EPS is closer to ₹0.79, and the adjusted P/E is roughly 72x. Using the numbers-claude estimate of ₹1.17 adjusted EPS (which normalizes differently), the adjusted P/E is ~49x. Neither number resembles 23.9x.

What to Underwrite Next

Five items to track next quarter:

1. Standalone trade receivables — if the receivable-to-revenue growth gap persists (receivables growing faster than revenue for a third consecutive year), cash conversion cannot improve regardless of volume execution. The specific line: standalone trade receivables versus quarterly revenue, targeting DSO under 110 days.

2. Operating cash flow versus PBT — strip DTA and other income. The clean test is whether CFO exceeds PBT minus a 25% normal tax rate. FY25 failed this test (CFO ₹1,092 cr vs adjusted NP ₹1,085 cr — barely passing). FY24 failed badly (CFO ₹80 cr vs adjusted NP ₹495 cr).

3. DTA balance and remaining carried-forward losses — the ₹638 cr DTA recognized in FY25 and ₹717 cr in Q2 FY26 draw down a finite pool of accumulated losses. When the pool is exhausted, headline NP will step down sharply. Disclose: how much unrecognized DTA remains, and at what pace will it be recognized.

4. Renom acquisition working-capital impact — the ₹660 cr acquisition completing in tranches could contribute acquired receivables/payables that distort underlying cash trends. Monitor whether CFO improvement coincides with consolidation of Renom's balance sheet.

5. Contingent liabilities — standalone contingent liabilities surged from ₹175 cr (FY24) to ₹479 cr (FY25), a 174% increase. Composition and resolution trajectory are unknown from available data.

What would downgrade the forensic score to "High" (61+):

• A third consecutive year of receivables growing faster than revenue
• CFO/NI falling below 0.30 on a trailing-twelve-month basis
• Disclosure that DTA recognition assumptions are being revised upward (accelerated recognition)
• Auditor qualification or emphasis-of-matter paragraph on receivable collectibility

What would upgrade the score to "Watch" (21–40):

• Two consecutive quarters of CFO exceeding reported net income
• Debtor days stabilizing below 110
• Full disclosure of receivable aging with the greater-than-one-year bucket under ₹500 cr
• Clean audit opinion on FY26 standalone with no restatements

The bottom line for position sizing: The accounting risk here is a valuation haircut and position-sizing limiter, not a thesis breaker. The operating business is real — MW deliveries, operating margins, and the order book are verifiable and strong. But the headline earnings multiple is fiction: P/E of 23.9x should be read as 49–72x depending on normalization. An investor underwriting at the headline multiple is underwriting the wrong number. The correct approach is to value on operating cash flow or normalized PBT, apply a 15–25% haircut for receivable risk, and size the position knowing that the next two quarters of DTA-free earnings will look like a sharp "earnings miss" to anyone anchored to the ₹2,072 cr FY25 headline. The forensic risk is that the market hasn't priced the normalization yet.

The People

Governance grade: B. The Tanti family runs Suzlon with minimal personal stake yet strong operational execution. Pay is modest, the board is competent, but promoter skin-in-the-game is thin and falling, and a governance lapse in 2024 signals the board cannot always check management.

The People Running This Company

The leadership transition is the story. Tulsi Tanti, Suzlon's visionary founder, passed away in October 2022. His brother Vinod stepped up as CMD. Rather than consolidating power, the family hired a professional CEO — first rehiring J.P. Chalasani, then in February 2026 bringing in Ajay Kapur, a heavyweight from Ambuja Cements, to lead the "Suzlon 2.0" diversification into solar, BESS, and integrated renewables. Chalasani was elevated to a strategic advisory body (Group Executive Council), not fired — suggesting an orderly succession, not a power struggle.

Pranav Tanti (Tulsi's eldest son, age 42) sits on the board as non-executive director. He has a strong track record: founded and exited a $500M wind portfolio (Skeiron Renewable Energy) via Hong Kong PE. His presence signals generational continuity without operational interference.

The CFO was also recently replaced: Himanshu Mody departed August 2025, replaced by Rahul Jain in December 2025. Two C-suite changes in quick succession is a signal to watch, though both moves appear planned rather than crisis-driven.

What They Get Paid

Verdict on pay: Vinod Tanti's ₹6.54 crore total is remarkably modest for a CMD of a ₹77,000+ crore market cap company. For context, FY2025 net profit was ₹2,072 crore — his pay is 0.3% of net profit. Girish Tanti drawing zero salary despite being Executive Vice Chairman is unusual and shareholder-friendly. Independent directors received one-time ex-gratia payments (₹8 lakh per year of association), approved by special resolution with 96%+ votes. No stock options exist for any director. This is a low-pay, low-perquisite setup.

Are They Aligned?

Ownership and Control

This is the weakest part of the governance story. Promoter holding has collapsed from 21% in FY2017 to 11.73% today. The drop is driven by three events:

1. Debt restructuring dilution (2018–2022): During the near-death experience of the CDR and debt restructuring, promoter stake was diluted through rights issues, equity conversions, and lender exits. The family participated in the ₹1,200 crore rights issue (Oct 2022) but could not prevent dilution.

2. QIP (2023): Suzlon raised ₹2,000 crore via qualified institutional placement at ~₹18.44/share, attracting institutional investors but diluting promoters.

3. Block deal (June 2025): The Tanti family sold ~₹1,309 crore worth of shares (~1.45% stake) via a block deal to Goldman Sachs, Morgan Stanley, and others. This is the most concerning event — promoters actively reducing skin-in-the-game.

Zero pledge is the silver lining. No promoter shares are pledged, unlike the 9.92% that was pledged to SBICAP Trustee as recently as 2022.

Promoter Group Breakdown

Tanti Holdings (5.14%) and Rambhaben Ukabhai (3.47%) hold the bulk. The CMD personally holds just 0.22%. Executive Vice Chairman Girish holds 0.73%. The promoter group's economic interest is concentrated in family trusts and holding companies rather than in the executives who run the company day-to-day.

Insider Activity

No insider buying or selling was reported in FY2025 (per annual report disclosure). The block deal in June 2025 is the only material promoter transaction. FIIs have been consistently adding — from 7.6% in FY2023 to 23.85% in FY2026, a strong institutional endorsement.

Related-Party Transactions

Per the proxy filing, the company states: "The Company does not have material pecuniary relationship or transactions with its Non-executive Directors except the payment of one-time ex-gratia amount and sitting fees." The Audit Committee reviewed and approved all related party transactions during FY25. The merger of subsidiary Suzlon Global Services Limited (SGSL) into the parent is the only structural related-party action — this is a simplification, not extraction.

Capital Allocation

Almost debt-free (net cash of ₹1,556 crore as of Dec 2025). No dividends paid despite ₹2,072 crore FY25 net profit. The company is reinvesting in capacity expansion (new blade factories, 4.5 GW manufacturing capacity) and the Suzlon 2.0 diversification. Retaining cash in a high-growth phase is defensible, but the combination of zero dividends + promoter selling creates a trust gap.

Skin-in-the-Game Score

Board Quality

Board composition: 7 directors — 2 executive (promoter), 1 non-executive (promoter), 4 independent. Half the board is independent, meeting SEBI requirements. A new independent director, Girish Vanvari (appointed February 2026), adds financial and tax expertise.

Strengths:

Per Hornung Pedersen is a genuine wind industry veteran — former CFO of Vestas/NEG Micon, former CEO of REpower (now Senvion). He doubled REpower's revenue to €1.2B and quadrupled EBITDA. He brings real domain expertise rare on Indian boards.

Gautam Doshi chairs the Audit Committee and has deep M&A and financial structuring experience. He serves on Sun Pharma and Piramal Enterprises boards.

Sameer Shah brings global banking/treasury experience (13 years at Deutsche Bank as MD, Asia Pacific equity services).

Flags:

Gautam Doshi was named as an accused in the 2G spectrum case as Group Managing Director of Reliance ADAG. He was acquitted by the special court in December 2017, and the ICAI Board of Discipline cleared him in October 2025. While fully exonerated, the fact that the Audit Committee Chairman carried this legal cloud for years is worth noting. The acquittal removes the concern.

Marc Desaedeleer resigned in June 2024 citing governance and transparency concerns. NSE and BSE issued advisory/warning letters to Suzlon for delayed and incomplete disclosure of the resignation. Suzlon denied financial irregularities but acknowledged the procedural lapse. This is a real governance red flag — an independent director quitting over transparency, followed by the company mishandling the disclosure.

Missing expertise: No director with deep solar, BESS, or energy storage background — a gap given the Suzlon 2.0 pivot.

The Verdict

Strongest positives:

Pay is genuinely modest — the CMD earns 0.3% of net profit with no stock options. The Vice Chairman draws zero salary. Independent directors approved ex-gratia via shareholder vote.

Almost debt-free balance sheet with zero promoter pledge, a dramatic turnaround from the 2018–2022 CDR era.

Hiring of professional CEO (Ajay Kapur) and orderly succession planning suggest the family knows it needs professional management for the next phase.

Strong institutional endorsement — FII holding rose from under 8% to nearly 24% in three years.

Real concerns:

Promoter holding at 11.73% and falling. The June 2025 block deal where the Tanti family sold ₹1,309 crore in shares to Goldman Sachs and Morgan Stanley is the single most concerning alignment signal. Promoters who sell during a strong execution phase send a mixed message.

The Desaedeleer resignation and SEBI warning reveal that governance standards slipped at least once under the current board. The company's delayed and incomplete disclosure was a clear procedural failure.

No dividends despite strong profitability, combined with promoter selling, creates a misalignment: the promoters monetize via share sales while minority shareholders get neither dividends nor buybacks.

One thing that would trigger an upgrade: Promoter group halting further stake sales and initiating either open-market buying or a meaningful dividend would close the alignment gap and push the grade toward B+/A-.

One thing that would trigger a downgrade: Another governance lapse, further promoter selling below 10%, or discovery of undisclosed related-party transactions would drop the grade toward C+.

What the Internet Reveals

Suzlon's web footprint tells a story the filings can't fully capture: a company executing a "Suzlon 2.0" global pivot into European wind markets while simultaneously managing a major leadership restructuring that replaced its CEO mid-flight. The most material web finding is the April 2026 unveiling of the "Blue Sky" platform (5 MW and 6.3 MW turbines) at WindEurope Madrid — this marks Suzlon's first serious international product since retreating from global markets during its debt crisis. Whether management can execute this two-front expansion (domestic ramp + Europe re-entry) while bedding in new leadership is the key question the filings alone don't answer.

What Matters Most

Recent News Timeline

Parser Error: syntax error at or near "union"

LINE 2: ...'BSE Filing' as source, 'Medium' as significance order by date union all
                                                                          ^

LINE 2: ...'BSE Filing' as source, 'Medium' as significance order by date union all
                                                                          ^

What the Specialists Asked

Insider Spotlight

No material insider trading activity was identified in the web research. Promoter holding has remained stable at 11.7% through recent quarters. The low promoter stake is a structural feature of Suzlon's post-restructuring capital structure, not a recent development.

Industry Context

India's wind energy sector is entering what multiple sources describe as a "Golden Era":

Government targets: India crossed 50 GW installed wind capacity and targets 100 GW by 2030 and 122 GW by 2032. The overall renewable target is 500 GW non-fossil fuel capacity by 2030.

Policy tailwinds: ALMM (Approved List of Models and Manufacturers) wind regulations effective July 2025 mandate domestic content, benefiting Suzlon's 90% localization. FDRE (Firm and Dispatchable Renewable Energy) project framework is driving large hybrid orders combining wind + solar + BESS.

Market growth: India's wind energy market projected to reach 89.49 GW by FY2030 (11.26% CAGR from 2025-2030). Annual installations expected to exceed 6.1 GW in FY27 — potentially highest ever.

Competitive landscape: Suzlon holds 32% domestic market share. Key competitors include Siemens Gamesa (now part of Siemens Energy), Vestas (limited India presence), and Envision Energy (Chinese). ALMM regulations create a significant barrier for Chinese OEMs.

Offshore opportunity: India's 71 GW offshore wind potential (Gujarat 36 GW, Tamil Nadu 35 GW) is largely untapped. Government VGF scheme of ₹7,453 Cr exists, with potential World Bank-backed expansion under discussion.

Social & Video

This section is separate from Web Research. It records the YouTube and X sources reviewed, the provider status, and any material off-filing signals that passed the social/video screen.

Provider Status

Material Signals

YouTube Sources Reviewed

X Searches Reviewed

X Source URLs Reviewed

Source Artifact

Normalized artifact: data/social-video/research.json

Liquidity & Technicals

Suzlon trades with deep institutional liquidity — average daily traded value of ₹647 Cr is roughly 0.84% of market cap and supports a 5% position for funds up to ~₹14,500 Cr (~$162M USD AUM equivalent at 20% ADV / five-day build), so liquidity is not the constraint here. The tape itself is the harder read: price has bounced 34% in a month, reclaimed the 200-day moving average, and is now overbought (RSI 77) while the 50-day average remains 8 rupees below the 200-day from the October-2025 death cross — a tactical squeeze inside an unfinished structural correction.

1. Portfolio implementation verdict

2. Price snapshot

3. The critical chart — ten years of price with 50/200 SMA

Price is above the 200-day by 6.7% as of 29 April 2026 (₹56.81 vs SMA200 ₹53.26). On the long view this is a stock that round-tripped from sub-₹2 in March 2020 to an all-time high of ₹86.04 in September 2024, then gave back 55% into March 2026 before this month's bounce — a sideways-to-recovering regime, not a clean uptrend.

4. Relative strength

The benchmark fetch did not populate (INDA series unavailable in this run), so the table above uses a public-knowledge reference for the broad Indian market over the same windows. Two observations stand: Suzlon has lagged the index by roughly 16 percentage points over the trailing year despite ending 2025 with a record order book and ₹15,029 Cr trailing revenue; and the entire one-year underperformance has been reversed in a single month of price action — a sign that positioning was light into the bounce, not that the structural relative strength has turned.

5. Momentum — RSI(14) and MACD histogram (last 18 months)

RSI hit 79.4 on 27 April 2026 — the highest reading on this 18-month window — and has begun to roll over (77.2 on 29 April). The MACD histogram peaked at 1.36 on 20 April and has printed three sequentially smaller positive bars since (1.36 → 1.08 → 0.90). The rally has not failed, but momentum is decelerating from an extreme — near-term the most likely outcome is consolidation or a shallow pullback rather than a vertical extension.

6. Volume, volatility and sponsorship

The 30-day daily-volume picture shows an unmistakable regime change in April 2026: 50-day average volume has stepped up from ~50M shares in February to 90M+ in late April, with two of the last three sessions printing volumes ~50% above the 50-day. The MACD/RSI surge is being confirmed by participation, not made by thin print. Earlier 2025 spikes (May, August) drove brief moves but did not establish durable trends — the volume-confirmed reclaim of the 200-day on rising 50-day participation in April 2026 is the cleanest sponsorship signal in the past nine months.

Realized 30-day vol is 45.2% — almost exactly at the 5-year median (p50 = 46.1%) and well below the stressed band (p80 = 63.6%). The market is not pricing crisis risk premium into Suzlon today; vol has compressed from the 2022 stretch when 30-day vol regularly cleared 75-85%, and from the late-2025 lull below the 25% mark when the stock was correcting on no participation. The 30-day reading is the calmest "uptrend regime" reading the stock has shown since early 2024.

7. Institutional liquidity panel

20-day ADV runs ~50% higher than 60-day, which means the April 2026 volume regime is materially above the trailing two-month base. Annualized turnover of roughly 158% (60-day-equivalent) ranks the name among the most actively traded large-cap industrials in India — a fund could in principle rotate the entire free-float twice in a year against current participation, so liquidity should not be the binding constraint on portfolio sizing.

Fund-capacity matrix

A fund that targets a 5% position weight and is willing to take 20% of the print can be up to roughly ₹14,500 Cr AUM (about $162M USD) before the position becomes a five-day-build. At more conservative 10% participation, the supported AUM at 5% weight halves to ~₹7,300 Cr (~$81M USD). For a 2% portfolio weight, the supported AUM scales to ₹36,400 Cr (~$405M USD) — the practical capacity-binding for most generalist Indian large-cap funds, though specialist concentrated portfolios will hit constraints sooner.

Liquidation runway

A 0.5% issuer-level stake (₹386 Cr) clears in three trading days at 20% ADV; a 1% stake takes a working week at 20% participation or two weeks at 10%. The 2% stake (₹1,546 Cr) is the threshold where exit becomes a multi-week project — and given Suzlon's historical 30-day vol percentile (currently p49, but routinely above p80 during stress), an institution sized at 2%+ should plan exit windows accordingly. Median 60-day daily range is 2.85%, well above the 2% threshold for "elevated impact cost" — meaning even in this liquid name, large blocks should expect material slippage on each marginal print.

The largest issuer-level position that clears in five days at 20% ADV participation is approximately 0.84% of market cap (₹728 Cr); at 10% ADV that compresses to 0.42% (₹364 Cr).

8. Technical scorecard and stance

Aggregate score: 0 / +6 ceiling. Stance: NEUTRAL on a 3-to-6-month horizon, with bullish tactical bias. The April 2026 reclaim of the 200-day SMA on a step-change in volume is real and not yet failed — but it is happening into RSI 77, with a fading MACD histogram and the 50/200 structure still death-crossed. Cross-referencing the Numbers tab: the same period that produced the price weakness (Q3-Q4 2025) was the period of strongest revenue acceleration (3Q26 revenue up 30% sequentially, ₹4,236 Cr) — a textbook fundamentals/price divergence that has now begun to close. The bullish case confirms above ₹62 — that level reclaims the upper Bollinger band, breaches the consolidation high of late October 2025, and would be the first technical event that pulls the SMA50 toward an SMA200 retest. The bearish case confirms below ₹50 — losing the 200-day after one month of overhead congestion would put the stock back inside the death-cross zone with momentum exhausted, and would re-test the ₹38.19 52-week low as the next durable support.

Liquidity is not the constraint. A fund of any size up to ~₹14,500 Cr AUM at a 5% position weight can implement here without becoming the market. The constraint is timing: this is a setup that argues for building over multiple weeks on pullbacks toward the SMA50 (₹45) rather than a maximum-conviction add at RSI 77. Watchlist for the ₹62 break; scale on the ₹50 hold.